| Predicting passive and active tissue: plasma partition coefficients: interindividual and interspecies variability CD Ruark, CE Hack, PJ Robinson, DA Mahle, JM Gearhart Journal of pharmaceutical sciences 103 (7), 2189-2198, 2014 | 47 | 2014 |
| Quantitative bias analysis for epidemiological associations of perfluoroalkyl substance serum concentrations and early onset of menopause CD Ruark, G Song, M Yoon, MA Verner, ME Andersen, HJ Clewell III, ... Environment international 99, 245-254, 2017 | 39 | 2017 |
| Development of a physiologically based model to describe the pharmacokinetics of methylphenidate in juvenile and adult humans and nonhuman primates X Yang, SM Morris, JM Gearhart, CD Ruark, MG Paule, W Slikker Jr, ... PloS one 9 (9), e106101, 2014 | 35 | 2014 |
| Quantitative structure–activity relationships for organophosphates binding to acetylcholinesterase CD Ruark, CE Hack, PJ Robinson, PE Anderson, JM Gearhart Archives of toxicology 87, 281-289, 2013 | 32 | 2013 |
| A physiologically based pharmacokinetic model for the oxime TMB-4: simulation of rodent and human data TR Sterner, CD Ruark, TR Covington, KO Yu, JM Gearhart Archives of toxicology 87 (4), 661-680, 2013 | 25 | 2013 |
| Quantitative bias analysis of a reported association between perfluoroalkyl substances (PFAS) and endometriosis: the influence of oral contraceptive use G Ngueta, MP Longnecker, M Yoon, CD Ruark, HJ Clewell 3rd, ... Environment international 104, 118-121, 2017 | 15 | 2017 |
| Quantitative structure–activity relationships for organophosphates binding to trypsin and chymotrypsin CD Ruark, CE Hack, PJ Robinson, JM Gearhart Journal of Toxicology and Environmental Health, Part A 74 (1), 1-23, 2010 | 14 | 2010 |
| High-throughput screening for positive allosteric modulators identified potential therapeutics against acetylcholinesterase inhibition RR Chapleau, CA McElroy, CD Ruark, EJ Fleming, AB Ghering, ... Journal of biomolecular screening 20 (9), 1142-1149, 2015 | 7 | 2015 |
| Physiologically based pharmacokinetic model: distribution processes C Ruark Physiologically Based Pharmacokinetic (PBPK) Modeling, 139-160, 2020 | 4 | 2020 |
| Organophosphorus inhibition and characterization of recombinant guinea pig acetylcholinesterase C D Ruark, R R Chapleau, D A Mahle, J M Gearhart Protein and Peptide Letters 22 (10), 862-868, 2015 | 3 | 2015 |
| Modeling Organophosphorus Chemical Warfare Nerve Agents: A Physiologically Based Pharmacokinetic–Pharmacodynamic (PBPK-PD) Model of VX TR Covington, LA Lumley, CD Ruark, ED Clarkson, CE Whalley, ... | 2 | 2016 |
| The Guinea Pig Model For Organophosphate Toxicology and Therapeutic Development CD Ruark Wright State University, 2015 | | 2015 |
| 2711 HPW/RHDJ, WPAFB OH TR Sterner, CD Ruark, TR Covington, KO Yu, JM Gearhart | | 2013 |
| Quantitative Structure-Activity Relationships for Organophosphate Enzyme Inhibition CD Ruark, CE Hack, PJ Robinson, JM Gearhart Parameters for Pesticide QSAR and PBPK/PD Models for Human Risk Assessment …, 2012 | | 2012 |
| Quantitative Structure-Activity Relationships for Organophosphate Enzyme Inhibition (Briefing Charts) C Ruark, K Yu | | 2011 |
